Group One Trading
ROIV icon

Group One Trading’s Roivant Sciences ROIV Stock Holding History

Group One Trading’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$751K Sell
27,100
-700,400
-96% -$18M ﹤0.01% 2962
2025
Q4 		$15.8M Buy
727,500
+30,900
+4% +$610K 0.03% 669
2025
Q3 		$10.5M Buy
696,600
+643,700
+1,217% +$7.97M 0.02% 873
2025
Q2 		$596K Buy
52,900
+22,700
+75% +$246K ﹤0.01% 3235
2025
Q1 		$305K Sell
30,200
-87,400
-74% -$945K ﹤0.01% 3566
2024
Q4 		$1.39M Sell
117,600
-24,500
-17% -$290K ﹤0.01% 2244
2024
Q3 		$1.64M Sell
142,100
-4,600
-3% -$52.4K ﹤0.01% 1882
2024
Q2 		$1.55M Buy
146,700
+86,600
+144% +$949K 0.01% 1649
2024
Q1 		$633K Sell
60,100
-460,700
-88% -$4.97M ﹤0.01% 2510
2023
Q4 		$5.85M Buy
520,800
+213,500
+69% +$2.08M 0.02% 1016
2023
Q3 		$3.59M Buy
307,300
+268,100
+684% +$3.03M 0.01% 1163
2023
Q2 		$395K Sell
39,200
-14,200
-27% -$127K ﹤0.01% 3250
2023
Q1 		$394K Sell
53,400
-9,200
-15% -$75.8K ﹤0.01% 2985
2022
Q4 		$500K Buy
+62,600
New +$348K ﹤0.01% 3042

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Group One Trading's ROIV Position: Q1 2026 in Review

Group One Trading opened a new position in Roivant Sciences (ROIV) in Q1 2026: 39,272 shares worth $1.09M. The stake represents ﹤0.01% of the portfolio and ranks #2628 among its holdings. This is a return to the name: Group One Trading previously reported a position in ROIV as recently as Q2 2025.

Group One Trading first reported a position in ROIV in Q3 2022 and has held it in 8 quarters since. 440 funds tracked by Wall St. Rank hold ROIV as of Q1 2026.

  • Group One Trading held 39,272 shares of Roivant Sciences worth $1.09M as of Q1 2026.
  • Roivant Sciences was a new Group One Trading position in Q1 2026.
  • Roivant Sciences made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #2628 holding.
  • Group One Trading first reported a position in Roivant Sciences in Q3 2022 and has held it in 8 quarters since.
  • 440 funds tracked by Wall St. Rank held Roivant Sciences as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.